These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 15272227
1. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000). Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M. Chemotherapy; 2004 Jun; 50(3):143-51. PubMed ID: 15272227 [Abstract] [Full Text] [Related]
2. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000). Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, Zoccoli CM, López H, Súcari A, Rossi F, Angulo GB, Segura AJ, Starling C, Mimica I, Felmingham D. Braz J Infect Dis; 2003 Feb; 7(1):44-61. PubMed ID: 12807691 [Abstract] [Full Text] [Related]
3. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001. Stratton CW, Brown SD. Clin Ther; 2004 Apr; 26(4):522-30. PubMed ID: 15189749 [Abstract] [Full Text] [Related]
8. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007]. Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX. Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2983-7. PubMed ID: 20137709 [Abstract] [Full Text] [Related]
9. Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern United States: data from the PROTEKT US surveillance program 2000/2001. Waites K, Brown S. South Med J; 2003 Oct 17; 96(10):974-85. PubMed ID: 14570341 [Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004). Inoue M, Farrell DJ, Kaneko K, Akizawa K, Fujita S, Kaku M, Igari J, Yamaguchi K, Yamanaka K, Murase M, Asari S, Hirakata Y, Baba H, Itaha H. Microb Drug Resist; 2008 Jun 17; 14(2):109-17. PubMed ID: 18500920 [Abstract] [Full Text] [Related]
11. In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program. Flamm RK, Rhomberg PR, Sader HS. Antimicrob Agents Chemother; 2017 Dec 17; 61(12):. PubMed ID: 28971877 [Abstract] [Full Text] [Related]
12. Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies. Low DE, Brown S, Felmingham D. Clin Microbiol Infect; 2004 Jan 17; 10(1):27-36. PubMed ID: 14706083 [Abstract] [Full Text] [Related]
13. Comparative activity of telithromycin against typical community-acquired respiratory pathogens. Buxbaum A, Forsthuber S, Graninger W, Georgopoulos A. J Antimicrob Chemother; 2003 Sep 17; 52(3):371-4. PubMed ID: 12888585 [Abstract] [Full Text] [Related]
14. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. Hoban D, Felmingham D. J Antimicrob Chemother; 2002 Sep 17; 50 Suppl S1():49-59. PubMed ID: 12239228 [Abstract] [Full Text] [Related]
15. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-3 (1999-2002). Inoue M, Kaneko K, Akizawa K, Fujita S, Kaku M, Igari J, Yamaguchi K, Kohno S, Yamanaka K, Iinuma Y, Murase M, Yokoyama T, Asari S, Hirakata Y. J Infect Chemother; 2006 Feb 17; 12(1):9-21. PubMed ID: 16506084 [Abstract] [Full Text] [Related]
16. In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agents. Ling TK, Lee CC. Chemotherapy; 2005 Jul 17; 51(4):182-5. PubMed ID: 15980628 [Abstract] [Full Text] [Related]
17. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y. Diagn Microbiol Infect Dis; 2012 Jun 17; 73(2):187-91. PubMed ID: 22521692 [Abstract] [Full Text] [Related]
18. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group. J Antimicrob Chemother; 2003 Aug 17; 52(2):229-46. PubMed ID: 12865398 [Abstract] [Full Text] [Related]
19. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children. Sunakawa K, Farrell DJ. Ann Clin Microbiol Antimicrob; 2007 Aug 13; 6():7. PubMed ID: 17697316 [Abstract] [Full Text] [Related]
20. Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired respiratory tract infections: the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study year 5 (2003-2004). Blasi F, Farrell DJ, Dubreuil L. Diagn Microbiol Infect Dis; 2009 Mar 13; 63(3):302-8. PubMed ID: 19135821 [Abstract] [Full Text] [Related] Page: [Next] [New Search]